Aptamer AS1411 (also known as AGRO100), a G-quartet DNA aptamer, can strongly bind to cell surface nucleolin and block the antiapoptotic pathway in cancer cells by combining with nuclear factor-kB essential modulator, which has reach phase II clinical trials as the first nucleic acid aptamer drug for the treatment of cancer in humans [10, 11]. The gene discussed is NUCLEOLIN; the disease is cancer.